Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX9FWF
|
||||
| Drug Name |
[2-(1H-Indol-4-yloxy)-ethyl]-[3-(1H-indol-3-yl)-propyl]-amine
|
||||
| Synonyms |
CHEMBL340301
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C21H23N3O
|
||||
| Canonical SMILES |
C(CNCCOc1cccc2[nH]ccc12)Cc3c[nH]c4ccccc34
|
||||
| InChI |
InChI=1S/C21H23N3O/c1-2-7-19-17(6-1)16(15-24-19)5-4-11-22-13-14-25-21-9-3-8-20-18(21)10-12-23-20/h1-3,6-10,12,15,22-24H,4-5,11,13-14H2
|
||||
| InChIKey |
FJYSNFYXXFBCDC-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.